ABASAGLAR

Active ingredients

The drug ABASAGLAR contains one active pharmaceutical ingredient (API):

UNII 2ZM8CX04RZ - INSULIN GLARGINE

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.

Read about Insulin glargine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

A10AE04

Insulin glargine

A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting

Discover more medicines within A10AE04

Authorization and marketing

This brand name is authorized in the following countries: Austria Cyprus Estonia Spain Finland France Ireland Lithuania Netherlands Poland Romania United Kingdom

This drug has been assigned below unique identifiers within the countries it is being marketed:

Ravimiamet

Identifier(s): 1664906, 1664917, 1664928, 1664939, 1665031, 1665042, 1665053, 1665064, 1856134, 1856145

Centro de información online de medicamentos de la AEMPS

Identifier(s): 114944012

Lääkealan turvallisuus- ja kehittämiskeskus

Identifier(s): 138421, 448060, 451991

Base de données publique des médicaments

Identifier(s): 64332894, 66513085

Medicines & Healthcare Products Regulatory Agency

Identifier(s): 301720, 301724

Health Products Regulatory Authority

Identifier(s): 69486

Valstybinė vaistų kontrolės tarnyba

Identifier(s): 1074462, 1074466, 1074467, 1080467, 1080470, 1080471, 1091116, 1091117

Z-Index G-Standaard, PRK

Identifier(s): 121312

Rejestru Produktów Leczniczych

Identifier(s): 100332006

Agenția Națională a Medicamentului și a Dispozitivelor Medicale

Identifier(s): W65160002, W65161001